Survival and Quality of Life after Isolated Hepatic Perfusion with Melphalan as a Treatment for Uveal Melanoma Liver Metastases - Final Results from the Phase III Randomized Controlled Trial SCANDIUM
Annals of surgery, 2024-02 [Peer Reviewed Journal]ISSN: 1528-1140 ;EISSN: 1528-1140 ;DOI: 10.1097/SLA.0000000000006255
Digital Resources/Online E-Resources